MICHAEL ATKINS

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology BOSTON, MA NPI 1306874201

General Payments — all program years on this page

$332,317.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 293
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $10,027.28 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $9,706.5010
Food and Beverage $320.783

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $110,668.77114
2019 $58,342.6861
2020 $43,457.0033
2021 $33,374.2422
2022 $40,358.7931
2023 $36,089.0219
2024 $10,027.2813

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101828161 E.R. Squibb & Sons, L.L.C. $922.50 02/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101828165 E.R. Squibb & Sons, L.L.C. $650.00 02/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101828275 E.R. Squibb & Sons, L.L.C. $10.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101828406 E.R. Squibb & Sons, L.L.C. $2,580.00 12/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117957826 Boehringer Ingelheim International GmbH $740.00 03/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117957828 Boehringer Ingelheim International GmbH $740.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117957830 Boehringer Ingelheim International GmbH $740.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1138561892 Exelixis Inc. $136.78 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138561894 Exelixis Inc. $174.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141615938 Merck Sharp & Dohme LLC $1,000.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1150209154 JAZZ PHARMACEUTICALS INC. $824.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1150209156 JAZZ PHARMACEUTICALS INC. $686.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1150209158 JAZZ PHARMACEUTICALS INC. $824.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.